Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilization Study and Impact Evaluation of the Therapeutic Initiative's Prescribing Portrait and Therapeutics Letter on HbA1c Testing

NCT06976541 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT06976541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06976541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilization Study and Impact Evaluation of the Therapeutic Initiative's Prescribing Portrait and Therapeutics Letter on HbA1c Testing
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 1, 2023
Completion date
May 1, 2027
Enrollment
968 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical audit, quality improvement, t2dm (type 2 diabetes mellitus)